Form 4 for SLS SELLAS Life Sciences Group, Inc.
Accepted 2025-06-13 00:00:00 ET · period of report 2025-06-12 · accession 0001104659-25-059166 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-13 | 2025-06-12 | SLS | VAN NOSTRAND ROBERT L | Dir | P - Purchase | $1.48 | +10.0K | 20.4K | +96% | +$14.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-12 | P | A | 10,000 | $1.48 | 20,400 | D | — | — |